New Insights on Steroid Biotechnology

Area of Science:

• Biotechnology
• Pharmaceutical Manufacturing
• Microbial Engineering

Background:

• Steroid manufacturing is a significant global industry, exceeding $10 billion annually.
• Current synthesis relies on combined microbiological and chemical processes using mycobacteria to convert sterols into intermediates.
• Existing microbial strains are primarily improved via traditional mutagenesis, with limited application of modern biology approaches.

Purpose of the Study:

• To review recent advancements in Steroid Biotechnology, focusing on recombinant DNA technologies.
• To highlight research on microbial transformation of sterols into key steroid precursors.
• To discuss future trends and the development of microbial cell factories for tailored steroid synthesis.

Main Methods:

• Review of scientific literature on Steroid Biotechnology over recent decades.
• Focus on studies employing recombinant DNA technologies for microbial strain improvement.
• Analysis of biocatalytic and chemical synthesis pathways for steroid active pharmaceutical ingredients (APIs).

Main Results:

• Identification of mycobacterial strains as key biocatalysts for sterol metabolism.
• Demonstration of microbial functionalization for regio- and stereospecific modifications of steroidal molecules.
• Highlighting the underutilization of Synthetic Biology and Systems Biology in this field.

Conclusions:

• Recombinant DNA technologies offer significant potential for improving steroid bioprocesses.
• There is a need for developing novel microbial cell factories for robust, bio-sustainable, and customizable steroid production.
• Future directions include engineering 'steroids à la carte' through advanced biotechnology.